Bay Harbor Wealth Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Bay Harbor Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	SELL	$62.39 - $113.8 $311 - $569	-5 Reduced 17.86%	23 $3,000
Q3 2022 Nov 02, 2022	SELL	$58.92 - $84.67 $54,088 - $77,727	-918 Reduced 97.04%	28 $2,000
Q2 2022 Aug 05, 2022	BUY	$79.4 - $116.36 $397 - $581	5 Added 0.53%	946 $75,000
Q4 2021 Feb 10, 2022	BUY	$98.56 - $119.91 $4,139 - $5,036	42 Added 4.67%	941 $88,000
Q3 2021 Nov 24, 2021	SELL	$91.91 - $110.37 $1,011 - $1,214	-11 Reduced 1.21%	899 $98,000
Q1 2021 May 05, 2021	BUY	$71.83 - $95.48 $63,066 - $83,831	878 Added 2743.75%	910 $84,000
Q3 2020 Oct 27, 2020	BUY	$55.23 - $79.93 $1,767 - $2,557	32 New	32 $2,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Bay Harbor Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bay Harbor Wealth Management, LLC with notifications on news.